MA28583B1 - Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormale - Google Patents
Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormaleInfo
- Publication number
- MA28583B1 MA28583B1 MA29452A MA29452A MA28583B1 MA 28583 B1 MA28583 B1 MA 28583B1 MA 29452 A MA29452 A MA 29452A MA 29452 A MA29452 A MA 29452A MA 28583 B1 MA28583 B1 MA 28583B1
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- cell growth
- abnormal cell
- pyrimidine derivatives
- pyrimidine
- Prior art date
Links
- 230000002159 abnormal effect Effects 0.000 title 1
- 230000010261 cell growth Effects 0.000 title 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57131204P | 2004-05-14 | 2004-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA28583B1 true MA28583B1 (fr) | 2007-05-02 |
Family
ID=34966230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA29452A MA28583B1 (fr) | 2004-05-14 | 2006-11-14 | Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormale |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1751143A1 (fr) |
| JP (1) | JP4099212B2 (fr) |
| KR (1) | KR100886990B1 (fr) |
| CN (2) | CN102127058A (fr) |
| AP (1) | AP2241A (fr) |
| AR (1) | AR049097A1 (fr) |
| AU (2) | AU2005243397A1 (fr) |
| BR (1) | BRPI0511138A (fr) |
| CA (1) | CA2566707A1 (fr) |
| CR (1) | CR8749A (fr) |
| EA (1) | EA200601796A1 (fr) |
| EC (1) | ECSP066997A (fr) |
| GE (1) | GEP20104875B (fr) |
| GT (1) | GT200500113A (fr) |
| IL (1) | IL178828A0 (fr) |
| MA (1) | MA28583B1 (fr) |
| MX (1) | MXPA06011890A (fr) |
| NL (2) | NL1029045C2 (fr) |
| NO (1) | NO20064576L (fr) |
| NZ (1) | NZ550448A (fr) |
| PA (1) | PA8632601A1 (fr) |
| PE (1) | PE20060240A1 (fr) |
| TN (1) | TNSN06370A1 (fr) |
| TW (1) | TWI303635B (fr) |
| UY (1) | UY28894A1 (fr) |
| WO (1) | WO2005111023A1 (fr) |
| ZA (1) | ZA200608394B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4812763B2 (ja) * | 2004-05-18 | 2011-11-09 | ライジェル ファーマシューティカルズ， インコーポレイテッド | シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途 |
| US20070032514A1 (en) * | 2005-07-01 | 2007-02-08 | Zahn Stephan K | 2,4-diamino-pyrimidines as aurora inhibitors |
| WO2007072158A2 (fr) * | 2005-12-21 | 2007-06-28 | Pfizer Products Inc. | Dérivés pyrimidiques destinés à traiter une croissance cellulaire anormale |
| DK2146779T3 (en) * | 2007-04-18 | 2016-11-28 | Pfizer Prod Inc | Sulfonylamid derivatives to treat abnormal cell growth. |
| AU2008275918B2 (en) * | 2007-07-17 | 2014-01-30 | Rigel Pharmaceuticals, Inc. | Cyclic amine substituted pyrimidinediamines as PKC inhibitors |
| WO2009071535A1 (fr) * | 2007-12-03 | 2009-06-11 | Boehringer Ingelheim International Gmbh | Nouveaux composés |
| MX2010012703A (es) * | 2008-05-21 | 2010-12-21 | Ariad Pharma Inc | Derivados fosforosos como inhibidores de cinasa. |
| US8410126B2 (en) * | 2009-05-29 | 2013-04-02 | Boehringer Ingelheim International Gmbh | Pyrimidine inhibitors of PKTK2 |
| EP2464633A1 (fr) | 2009-08-14 | 2012-06-20 | Boehringer Ingelheim International GmbH | Préparation régiosélective de dérivés de 2-amino-5-trifluorométhylpyrimidine |
| US8933227B2 (en) | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
| US20120244141A1 (en) | 2010-09-28 | 2012-09-27 | Boehringer Ingelheim International Gmbh | Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors |
| WO2014174745A1 (fr) * | 2013-04-26 | 2014-10-30 | 国立大学法人京都大学 | INHIBITEUR D'Eg5 |
| CN109608444B (zh) * | 2018-11-27 | 2022-02-11 | 中国药科大学 | 含异吲哚啉酮的erk抑制剂及其制备方法与用途 |
| CN111732548B (zh) * | 2020-06-11 | 2022-06-17 | 浙江大学 | N2-氨甲酰芳环-2-氨基嘧啶类衍生物及其医药用途 |
| WO2024140671A1 (fr) * | 2022-12-29 | 2024-07-04 | 南京昕瑞再生医药科技有限公司 | Dérivé tricyclique fusionné, composition pharmaceutique le comprenant et son utilisation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9721437D0 (en) * | 1997-10-10 | 1997-12-10 | Glaxo Group Ltd | Heteroaromatic compounds and their use in medicine |
| AR042586A1 (es) | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
| WO2003030909A1 (fr) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- et 4-aminopyrimidines n-substituees par un noyau bicyclique utilisees comme inhibiteurs de kinases dans le traitement du cancer |
| CA2529611C (fr) * | 2002-12-20 | 2009-12-15 | Pfizer Products Inc. | Derives de pyrimidine destines au traitement de la croissance cellulaire anormale |
| UA80767C2 (en) * | 2002-12-20 | 2007-10-25 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
-
2005
- 2005-05-02 WO PCT/IB2005/001201 patent/WO2005111023A1/fr not_active Ceased
- 2005-05-02 NZ NZ550448A patent/NZ550448A/en not_active IP Right Cessation
- 2005-05-02 EA EA200601796A patent/EA200601796A1/ru unknown
- 2005-05-02 CN CN2011100212904A patent/CN102127058A/zh active Pending
- 2005-05-02 KR KR1020067023767A patent/KR100886990B1/ko not_active Expired - Lifetime
- 2005-05-02 EP EP05732043A patent/EP1751143A1/fr not_active Withdrawn
- 2005-05-02 CN CNA2005800155302A patent/CN1953974A/zh active Pending
- 2005-05-02 BR BRPI0511138-2A patent/BRPI0511138A/pt not_active IP Right Cessation
- 2005-05-02 AP AP2006003790A patent/AP2241A/xx active
- 2005-05-02 CA CA002566707A patent/CA2566707A1/fr not_active Abandoned
- 2005-05-02 MX MXPA06011890A patent/MXPA06011890A/es unknown
- 2005-05-02 GE GEAP20059703A patent/GEP20104875B/en unknown
- 2005-05-02 JP JP2007512557A patent/JP4099212B2/ja not_active Expired - Lifetime
- 2005-05-02 AU AU2005243397A patent/AU2005243397A1/en not_active Abandoned
- 2005-05-11 TW TW094115237A patent/TWI303635B/zh not_active IP Right Cessation
- 2005-05-11 PA PA20058632601A patent/PA8632601A1/es unknown
- 2005-05-12 UY UY28894A patent/UY28894A1/es not_active Application Discontinuation
- 2005-05-12 PE PE2005000534A patent/PE20060240A1/es not_active Application Discontinuation
- 2005-05-13 GT GT200500113A patent/GT200500113A/es unknown
- 2005-05-13 NL NL1029045A patent/NL1029045C2/nl not_active IP Right Cessation
- 2005-05-13 AR ARP050101969A patent/AR049097A1/es not_active Application Discontinuation
-
2006
- 2006-05-19 NL NL1031845A patent/NL1031845C2/nl not_active IP Right Cessation
- 2006-10-06 ZA ZA200608394A patent/ZA200608394B/xx unknown
- 2006-10-09 NO NO20064576A patent/NO20064576L/no not_active Application Discontinuation
- 2006-10-23 IL IL178828A patent/IL178828A0/en unknown
- 2006-11-13 CR CR8749A patent/CR8749A/es not_active Application Discontinuation
- 2006-11-13 EC EC2006006997A patent/ECSP066997A/es unknown
- 2006-11-13 TN TNP2006000370A patent/TNSN06370A1/fr unknown
- 2006-11-14 MA MA29452A patent/MA28583B1/fr unknown
-
2009
- 2009-11-13 AU AU2009238255A patent/AU2009238255A1/en not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1831385A4 (fr) | Enzymes pour le traitement d'amidon | |
| MA28583B1 (fr) | Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormale | |
| MA28481B1 (fr) | Dérivés d'imidazole pour le traitement de troubles neurodégénératifs | |
| FR13C0029I2 (fr) | Compositions pour le traitement de troubles gastro-intestinaux | |
| NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
| AP2385A (en) | Pyrimidine derivatives for the treatment of abnormal cell growth. | |
| EP1807396A4 (fr) | Composes de 2-aminopyridine utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
| EP1893224A4 (fr) | Utilisation d'une membrane de cellule vegetale pour le traitement de l'obesite | |
| CL2003002293A1 (es) | Compuestos derivados de indazol; su composicion farmaceutica; su uso en el tratamiento de hipertension ocular. | |
| FR2860154B1 (fr) | Composition pour le traitement de la mauvaise haleine | |
| EP1581243A4 (fr) | Lactoferrine orale pour le traitement des sepsies | |
| FR2871365B1 (fr) | Implant pour le traitement de la rectocele ou de la cystocele | |
| EP1750513A4 (fr) | Utilisation de ligands gpcr54 pour le traitement de l'infertilite | |
| FR2835851B1 (fr) | Composition pour le traitement d'alliages de magnesium | |
| EP1572129A4 (fr) | Derives d'amidine pour le traitement des amyloses | |
| EP2229172A4 (fr) | Composés de triazolo [4,5-d] pyrimidine pour le traitement d'anévrysmes aortiques abdominaux | |
| FR2869622B1 (fr) | Comprimes de micro-organismes pour ensemencement direct | |
| PL1687006T3 (pl) | Kompozycje farmaceutyczne do leczenia zaburzeń czynności nerek | |
| FR2887456B1 (fr) | "composition pour le traitement de la dermite estivale" | |
| EP1828141A4 (fr) | Procede monotope de preparation de l'agent antiemetique 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one | |
| UA80871C2 (en) | 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension | |
| FR2849599B1 (fr) | Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete | |
| FR2852252B1 (fr) | Valve implantable pour le traitement de l'hydrocephalie | |
| FR2851247B1 (fr) | Methodes et compositions pour le traitement de pathologies degeneratives oculaires | |
| MA28513B1 (fr) | Processus pour la preparation d'inhibiteurs de tryptase |